T A Pigott
Overview
Explore the profile of T A Pigott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pigott T
J Clin Psychiatry
. 1999 Sep;
60 Suppl 18:4-15.
PMID: 10487250
Women are more likely than men to develop anxiety disorders. Yet, relatively few studies have investigated whether women with anxiety disorders have characteristics that are distinct from those of men...
2.
Crismon M, Trivedi M, Pigott T, Rush A, Hirschfeld R, Kahn D, et al.
J Clin Psychiatry
. 1999 Apr;
60(3):142-56.
PMID: 10192589
Background: This article describes the development of consensus medication algorithms for the treatment of patients with major depressive disorder in the Texas public mental health system. To the best of...
3.
A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder
Pigott T, Seay S
J Clin Psychiatry
. 1999 Mar;
60(2):101-6.
PMID: 10084636
Background: Obsessive-compulsive disorder (OCD) is a chronic illness associated with substantial morbidity; it often requires long-term medication. The best-studied therapeutic agent in the treatment of this disorder is the tricyclic...
4.
Pigott T
Bull Menninger Clin
. 1998 Nov;
62(4 Suppl A):A4-32.
PMID: 9810775
Obsessive-compulsive disorder (OCD) is associated with substantial psychosocial impairment. Although large-scale population surveys suggest that OCD is fairly common, relatively few individuals receive adequate treatment. OCD symptoms characterized by "altered...
5.
Broocks A, Pigott T, Hill J, CANTER S, Grady T, Lheureux F, et al.
Psychiatry Res
. 1998 Jul;
79(1):11-20.
PMID: 9676822
Obsessive-compulsive disorder (OCD) has been linked to abnormal function of brain serotonin (5-HT) pathways. Since ondansetron is a highly selective 5-HT3 receptor antagonist, the present study was undertaken to investigate...
6.
Broocks A, Briggs N, Pigott T, Hill J, Canter S, Tolliver T, et al.
Psychopharmacology (Berl)
. 1997 Mar;
130(2):91-103.
PMID: 9106905
Several serotonin3 (5-HT3) antagonists have been shown to attenuate the anxiogenic effects of the serotonergic agent, m-chlorophenylpiperazine (m-CPP), in animal models, but little data regarding possible effects of 5-HT3 antagonists...
7.
Grady T, Broocks A, Canter S, Pigott T, Dubbert B, Hill J, et al.
Psychiatry Res
. 1996 Aug;
64(1):1-10.
PMID: 8888359
Evidence that serotonin3 (5-hydroxytryptamine3, 5-HT3) antagonists attenuate behavioral responses to D-amphetamine and cocaine suggests that 5-HT3 receptors modulate brain dopamine in animals. This study examined the potential interactions of the...
8.
Bastiani A, Altemus M, Pigott T, Rubenstein C, Weltzin T, Kaye W
Biol Psychiatry
. 1996 Jun;
39(11):966-9.
PMID: 9162209
Patients with anorexia nervosa (n = 18) and patients with obsessive-compulsive disorder (OCD) (n = 16) had similar scores on the Yale-Brown Obsessive Compulsive Scale (19 + or - 9...
9.
Pigott T
J Clin Psychiatry
. 1996 Jan;
57 Suppl 6:11-20.
PMID: 8647793
Since concomitant anxiety is frequent and prominent, obsessive-compulsive disorder (OCD) is classified as an anxiety disorder. However, effective antidepressant and anxiolytic agents that are nonserotonin-selective are generally ineffective in significantly...
10.
Demitrack M, Heyes M, Altemus M, Pigott T, Gold P
Biol Psychiatry
. 1995 Apr;
37(8):512-20.
PMID: 7542489
In brain, most L-tryptophan is metabolized to indoleamines, whereas in systemic tissues L-tryptophan is catabolized to kynurenine pathway metabolites. Among these latter compounds are: quinolinic acid, an N-methyl-D-aspartate receptor agonist;...